Skip to main content

Stryker Value Stock - Dividend - Research Selection

Stryker

ISIN: US8636671013 , WKN: 864952

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 85 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Tech Takes Spotlight In Busy Earnings Week As Apple, Microsoft, Meta Report Results

2025-01-25
Big tech names report earnings this week. Fed's interest rate decision is to be announced on Wednesday. Stay updated on upcoming events with this newsletter.

Dividend Champion, Contender, And Challenger Highlights: Week Of January 26

2025-01-25
Stay informed with weekly updates on dividend activity for Dividend Champions, Contenders, and Challengers, including changes and upcoming dates.

Stryker Corp. stock underperforms Wednesday when compared to competitors

2025-01-22
Stryker Corp. stock underperforms Wednesday when compared to competitors

Baron Health Care Fund Q4 2024 Shareholder Letter

2025-01-22
Baron Health Care Fund retreated in the fourth quarter of 2024, in line with its benchmark, the Russell 3000 Health Care Index. Read more here.

Stryker Corp. stock outperforms competitors on strong trading day

2025-01-21
Stryker Corp. stock outperforms competitors on strong trading day

Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.

2025-01-20
Portage, Michigan - Stryker today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and outstanding...

Stryker Corp. stock rises Wednesday, still underperforms market

2025-01-15
Stryker Corp. stock rises Wednesday, still underperforms market

Stryker Corp. stock underperforms Tuesday when compared to competitors despite daily gains

2025-01-14
Stryker Corp. stock underperforms Tuesday when compared to competitors despite daily gains

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025

2025-01-13
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025

Fundsmith Equity Fund 2024 Annual Letter To Shareholders

2025-01-13
Our Fund is the second-best performer since its inception in November 2010 in the Investment Association Global sector of 162 funds. Read more here.